3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis Complex-associated Refractory Seizures
1
Interventions
Everolimus
1
Anticonvulsants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Tuberous Sclerosis Complex-associated Refractory Seizures
×
Anticonvulsants
×
Clear all
NCT01713946
2018-11-07
EXIST-3
Novartis
Phase 3
Completed
366 enrolled
38 charts
1 FDA